Biogen Swings to Quarterly Loss as Sales Rise
Biogen reported a third-quarter loss of $20.6 million, or 14 cents a share, compared with a year-earlier profit of $466.5 million, or $3.17 a share. Sales increased.
By Katherine HamiltonBiogen swung to a loss in the third quarter due to higher expenses, but logged sales growth.The biotechnology company posted a quarterly loss of $20.6 million, or 14 cents a share, compared with a profit of $466.5 million, or $3.17 a share, a year earlier.The swing to a loss wa…